GCM
GPCR icon

Graham Capital Management’s Structure Therapeutics GPCR Stock Holding History

Graham Capital Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,908
Closed -$206K – 1404
2025
Q1 		$206K Buy
+11,908
New +$292K ﹤0.01% 1128

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Graham Capital Management's GPCR Position: Q2 2025 in Review

Graham Capital Management sold out of Structure Therapeutics (GPCR) in Q2 2025, closing a stake of 11,908 shares — an estimated $206K sold.

Graham Capital Management first reported a position in GPCR in Q1 2025 and held it in 1 quarter. The position peaked at $206K in Q1 2025. 172 funds tracked by Wall St. Rank hold GPCR as of Q2 2025.

  • Graham Capital Management reported no remaining Structure Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Graham Capital Management sold 11,908 Structure Therapeutics shares in Q2 2025, an estimated $206K.
  • Graham Capital Management first reported a position in Structure Therapeutics in Q1 2025 and held it in 1 quarter.
  • Graham Capital Management's Structure Therapeutics position peaked at $206K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2025.

Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.